● IndustryOct 29, 2026 · 07:238 sources
Mithril Founder Cody Tranbarger Reveals 'Professor Oak' Identity After July Anthropic Sale
From marketbrief.now
AI;DR
Mithril Medicine founder Cody Tranbarger revealed he operated the anonymous biotech account 'Professor Oak' for six years as Anthropic disclosed it acquired his single-person company in July for an undisclosed price. Tranbarger joined Anthropic to continue Mithril's programs for LAMA2-related congenital muscular dystrophy and alpha-dystroglycanopathy, and to start new drug programs using a 'Pipeline in a Person' model with Claude.
Read originalSign in to suggest
Sources
+ 6 more
- SUPPORT@andrewcurran_“On day 4, the production CRO delivered its data package, a report of 341 pages, which one of us forwarded to Claude in two sentences, with the request to review it, share observations and recommend next steps. Claude returned a bottom line after 2 min 40s and, once it had read every page, a visual synthesis of all 113 constructs after 7 min 53s.”x.com
- SUPPORT@andrewcurran_“Before it was acquired by Anthropic in July, Mithril had only one full-time employee: its founder, Cody Tranbarger.”x.com
- SUPPORT@hesamation“Just one day after filing for its IPO, Anthropic announces it’s getting into drug discovery ITSELF. so basically the AI company that sells tokens to an entire industry may eventually compete with its own customers.”x.com
- SUPPORT@pitdesi“Over the past few months, Anthropic scientists have engaged in deep research partnerships with six organizations developing new medicines. We've also begun drug discovery efforts of our own.”x.com
- SUPPORT@cz_binance“The limiting factor will become the 10 year trial/approval process. Maybe they will also use AI to review and approve?”x.com
- SUPPORT@mtslive“In a 6-week mouse study, the highest dose roughly doubled grip strength, and 1 of 8 treated mice died vs 4 of 8 untreated”x.com